Most of the current studies suggest that inflammatory cells in PI infiltrate the prostate epithelium, causing its destruction and release of excessive PSA, and that the prostatic ducts and the original physiological barrier in BPH patients with PI are severely disrupted by inflammation and PSA leaks into the circulation, leading to elevated serum PSA levels (21–23). Here, KLK3 is linked to benign prostatic hyperplasia.